Natco Pharma

Egenesis Inc. is a biotechnology company focused on gene editing and genome engineering to create human transplantable organs, tissues, and cells. Established in 2015 and headquartered in Cambridge, Massachusetts, with an additional office in New York City, Egenesis aims to address the global organ shortage by developing solid organs and therapeutic cell transplantation solutions for various diseases. The company utilizes a gene editing platform that incorporates techniques such as single-cell cloning and somatic cell nuclear transfer, which are essential for creating human-compatible organ tissues and cells. Egenesis is particularly engaged in advancing programs related to kidney and islet cell transplantation, striving to provide alternative treatment options for patients with life-threatening conditions.

Cellogen Therapeutics is a biotechnology company focused on developing innovative cell therapy solutions for the healthcare industry. It specializes in CAR-T cell-based therapies aimed at treating various hematological malignancies, solid tumors, and hemoglobinopathies. By utilizing advanced cellular engineering tools and gene therapy techniques, Cellogen Therapeutics strives to provide effective and cost-efficient options for patients facing cancer and metabolic diseases.

Pee Safe, established in 2013, is a company specializing in personal hygiene products aimed at promoting cleanliness and hygiene, particularly in restroom environments. Initially launching a toilet seat sanitizer, the company has since diversified its offerings to include a range of products in various hygiene categories, such as feminine hygiene items like pads, tampons, and menstrual cups, as well as men's intimate hygiene, hand hygiene solutions, and face masks. Pee Safe emphasizes ethical practices by ensuring that its products are vegan and cruelty-free, catering to consumers who prioritize both hygiene and ethical considerations in their purchasing decisions. The company has positioned itself as a leader in several sub-categories within the personal hygiene market.

Eyestem is a cell therapy company focused on developing scalable therapies to treat incurable diseases, with a particular emphasis on conditions such as age-related macular degeneration (Dry AMD). Founded by a team of experts in clinical trials, cell therapy, and ophthalmology, the company is supported by a distinguished advisory board and has established collaborations with leaders in the field. Eyestem aims to create a global and accessible cell therapy platform that ensures consistent quality and efficacy in its products, ultimately democratizing access to advanced treatment technologies for patients worldwide. Over the coming years, the company will concentrate on refining its platform to enhance safety and effectiveness in its therapeutic offerings.

Dash Pharmaceuticals is a New Jersey-based company focused on the sales, marketing, and distribution of pharmaceutical products within the United States. Specializing in generic drugs, the company co-develops and licenses a variety of products, including nutritional and dietary supplements, vitamins, and topical treatments. These products are offered in multiple dosage forms and are packaged under the company's own label, allowing Dash Pharmaceuticals to effectively serve the needs of the market.

CION Cancer Clinics manages a network of day-care cancer treatment centers located in Telangana and Andhra Pradesh. The organization focuses on providing precise and individualized care for cancer patients, offering services that include treatment, detection, and awareness of cancer-related diseases. By empowering individuals with essential support services and information, CION aims to enhance patient autonomy in managing their health. The centers are designed to provide medical support, companionship, and empathy, ensuring that patients receive comprehensive care during their recovery process.

PACE Hospitals operates a hospital chain that provides quality care for a wide range of tertiary healthcare services with personalized and ethical next-gen medicare. PACE delivers advanced procedures at a fraction of the international costs through relentless research and innovation. PACE Hospitals focuses on tertiary care services in the field of medical gastroenterology, surgical gastroenterology, hepatology, nephrology, urology, oncology, orthopedics, pulmonology, gynecology, ENT, cardiology, general medicine & diabetology, endocrinology, general surgery, critical care, cosmetic & plastic surgery, dermatology, neurology, neurosurgery, psychiatry, rheumatology, and andrology.